20/20 BIOLABS, INC.: operating_lease_liability
| Value | {"amount": 572448, "concept": "us-gaap:OperatingLeaseLiability", "currency": "USD"} |
|---|---|
| Period | (as of 2026-06-30) |
| Status | current |
| Entity | 20/20 BIOLABS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:27:01.038089+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/e63663ab-9925-4b51-8f2c-e5910e5c8832
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-26-090042 · Open the official SEC filing →Retrieved: 2026-08-19T11:27:01.038089+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001139685/operating-lease-liability/2026-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/e63663ab-9925-4b51-8f2c-e5910e5c8832
History
- no predecessors — first report